The Beijing-based Synovac Biotech vaccine - called Coronavac - is being introduced to the city of Jiaxing, specifically to care for epidemic prevention workers, public service personnel and port inspectors, and eventually for regular citizens Will, state media reported Friday, quoting officials.
The news agency Reuters reported that the Synovac vaccine is undergoing late-stage trials in Brazil, Indonesia and Turkey, and the company said an interim analysis of Phase 3 trial data could take place in early November. (AP file photo)
An experimental coronovirus disease (Covid-19) vaccine is being offered outside of clinical testing for $ 60 for high-risk groups under an emergency vaccination program in a city in eastern China, officials said. That even the experts have expressed concern over the widespread concern — that is, the unproven vaccine.
___________________________________________
The Beijing-based Synovac Biotech vaccine - called Coronavac - is being introduced to the city of Jiaxing, specifically to care for epidemic prevention workers, public service personnel and port inspectors, and eventually for regular citizens Will, state media reported Friday, quoting officials.
___________________________________________
The Jiaxing Center for Disease Control and Prevention (CDC) said, "The vaccine, developed by Chinese company Sinovac Biotech, will be provided to people aged 18 to 59 at a price of 400 yuan ($ 59.5) for two shots." The vaccine has not been "officially approved for marketing" and is only approved for "immediate needs".
___________________________________________
However, the Jiaxing CDC did not specify what constituted "immediate needs".
___________________________________________
Officials also did not say how many people would be given the vaccine in the city, which comes in two doses at intervals of 14–28 days.
___________________________________________
The news agency Reuters reported that the Synovac vaccine is in late-stage trials in Brazil, Indonesia and Turkey, and the company said that an interim analysis of Phase 3 trial data could take place in early November.
___________________________________________
In late June, China's National Health Commission (NHC), under the Chinese Vaccine Management Act, was permitted to use emergency vaccines on people at high risk of contracting the deadly virus, including medical staff, Includes border epidemic activists and customs. Vaccines are still on a footstep as a move by activists - considered controversial by experts. Since July, China has administered such vaccines to hundreds of thousands of people under the program.
___________________________________________
On 25 September, a top Chinese health official said that Beijing had received "understanding and support" from the World Health Organization (WHO) before launching an emergency use program. In an emailed statement to HT the next day, the WHO said China's decision to launch the program was a domestic authority. "These are issued at the discretion of countries and are not subject to WHO approval," it said.
___________________________________________
By the end of September, 11 Chinese Covid-19 vaccines had entered clinical trials, with four in Phase 3 clinical trials.
___________________________________________
Last week, China announced it would join COVAX, an international initiative aimed at ensuring equal global access to Covid-19 vaccines, becoming the largest economy to support the initiative. has gone.
___________________________________________
The number of daily cases of Covid-19 in mainland China has fallen significantly from the peaks seen in February.
___________________________________________
The total number of confirmed Covid-19 cases in mainland China is over 85,500, while the death toll remained unchanged at 6,634.
________________**********_________________